WinstonWınston
Haoxi Health Technology Limited logo

Haoxi Health Technology Limited

HAO
22
Advertising Agencies · Communication Services
Price
$0.15
+0.00 (+3.07%)
Market Cap
$9,056
Exchange
NASDAQ Capital Market
Winston Score
22
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 9, 2026 · filings through Dec 31, 2025

Share count falling — buybacks

76.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 10.0M (2021) → 2.4M (2025)

Haoxi Health Technology Limited is a small Chinese company that provides digital advertising services, mainly focused on the health and wellness industry. It helps health-related businesses — such as pharmaceutical companies, medical device makers, and wellness brands — reach consumers through online platforms and social media channels in China. The company acts as a middleman, connecting advertisers with digital media inventory.

Haoxi makes money by buying advertising space on digital platforms and reselling it to clients at a markup, which explains its very thin gross margin of around 5%. The company operates almost entirely in China and is quite small, with a market cap near zero. Its financial metrics, including a deeply negative operating margin and poor return on invested capital, signal that the business is currently spending more than it earns. The key risk is whether the company can scale its client base and improve margins in China's highly competitive digital advertising market, where larger players like Alibaba and Tencent dominate.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+41.2% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

<−1,000% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$79,544/ year

Flat (-1% vs prior year)

0.2% of revenue

Below sector average (12%)

Steady R&D investment year-over-year

Insider Activity

62.1%ownership

Insiders own a meaningful stake in the company

Cash Runway

~15 months

$11M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

Revenue accelerating

Haoxi Health Technology Limited grew revenue 41% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
4.7%
Thin — 4.7% gross margin
Operating Margin
-16.8%
Losing money on operations — -16.8%
ROCE
-32.4%
Weak — -32.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-12.9%
Shrinking sales (-12.9% YoY)
EPS YoY
-479.3%
Earnings shrinking (-479.3% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-7.9%
Burning cash (-7.9%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.10
Conservative — low debt load (0.10)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial